Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Hospitalization Risk among Older Adults with Chronic Kidney Disease.

Wong E, Ballew SH, Daya N, Ishigami J, Rebholz CM, Matsushita K, Grams ME, Coresh J.

Am J Nephrol. 2019 Jul 16:1-9. doi: 10.1159/000501539. [Epub ahead of print]

PMID:
31311014
2.

Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data.

Grams ME, Sang Y, Ballew SH, Matsushita K, Astor BC, Carrero JJ, Chang AR, Inker LA, Kenealy T, Kovesdy CP, Lee BJ, Levin A, Naimark D, Pena MJ, Schold JD, Shalev V, Wetzels JFM, Woodward M, Gansevoort RT, Levey AS, Coresh J.

J Am Soc Nephrol. 2019 Jul 10. pii: ASN.2019010008. doi: 10.1681/ASN.2019010008. [Epub ahead of print]

PMID:
31292199
3.

Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction.

Mok Y, Ballew SH, Sang Y, Grams ME, Coresh J, Evans M, Barany P, Ärnlöv J, Carrero JJ, Matsushita K.

J Am Heart Assoc. 2019 Apr 16;8(8):e010546. doi: 10.1161/JAHA.118.010546.

4.

Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium.

Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, Gutierrez OM, Hosseinpanah F, Iseki K, Kenealy T, Klein B, Kronenberg F, Lee BJ, Li Y, Miura K, Navaneethan SD, Roderick PJ, Valdivielso JM, Visseren FLJ, Zhang L, Gansevoort RT, Hallan SI, Levey AS, Matsushita K, Shalev V, Woodward M; CKD Prognosis Consortium (CKD-PC).

BMJ. 2019 Jan 10;364:k5301. doi: 10.1136/bmj.k5301.

5.

Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKD.

Novick TK, Surapaneni A, Shin JI, Ballew SH, Alexander GC, Inker LA, Chang AR, Grams ME.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1886-1888. doi: 10.2215/CJN.08530718. Epub 2018 Nov 8. No abstract available.

PMID:
30409899
6.

Chronic kidney disease measures and the risk of abdominal aortic aneurysm.

Matsushita K, Kwak L, Ballew SH, Grams ME, Selvin E, Folsom AR, Coresh J, Tang W.

Atherosclerosis. 2018 Dec;279:107-113. doi: 10.1016/j.atherosclerosis.2018.08.043. Epub 2018 Sep 1.

PMID:
30290962
7.

Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.

Secora A, Alexander GC, Ballew SH, Coresh J, Grams ME.

Drugs Aging. 2018 Aug;35(8):735-750. doi: 10.1007/s40266-018-0563-1.

PMID:
30039344
8.

Associations Between Kidney Disease Measures and Regional Pulse Wave Velocity in a Large Community-Based Cohort: The Atherosclerosis Risk in Communities (ARIC) Study.

Kim ED, Tanaka H, Ballew SH, Sang Y, Heiss G, Coresh J, Matsushita K.

Am J Kidney Dis. 2018 Nov;72(5):682-690. doi: 10.1053/j.ajkd.2018.04.018. Epub 2018 Jul 12.

PMID:
30007506
9.

International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.

Mok Y, Ballew SH, Bash LD, Bhatt DL, Boden WE, Bonaca MP, Carrero JJ, Coresh J, D'Agostino RB Sr, Elley CR, Fowkes FGR, Jee SH, Kovesdy CP, Mahaffey KW, Nadkarni G, Peterson ED, Sang Y, Matsushita K.

J Am Heart Assoc. 2018 Jul 7;7(14). pii: e008426. doi: 10.1161/JAHA.117.008426.

10.

Socioeconomic status and risk of kidney dysfunction: the Atherosclerosis Risk in Communities study.

Vart P, Grams ME, Ballew SH, Woodward M, Coresh J, Matsushita K.

Nephrol Dial Transplant. 2018 Jun 11. doi: 10.1093/ndt/gfy142. [Epub ahead of print]

PMID:
29897587
11.

Cardiovascular Risk Prediction in CKD.

Ballew SH, Matsushita K.

Semin Nephrol. 2018 May;38(3):208-216. doi: 10.1016/j.semnephrol.2018.02.002. Review.

PMID:
29753398
12.

Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.

Ding N, Kwak L, Ballew SH, Jaar B, Hoogeveen RC, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Salameh M, Coresh J, Hirsch AT, Selvin E, Matsushita K.

Atherosclerosis. 2018 Jul;274:86-93. doi: 10.1016/j.atherosclerosis.2018.04.042. Epub 2018 Apr 30.

13.

Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.

Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, Ho K, Ito S, Marks A, Naimark D, Nash DM, Navaneethan SD, Sarnak M, Stengel B, Visseren FLJ, Wang AY, Köttgen A, Levey AS, Woodward M, Eckardt KU, Hemmelgarn B, Coresh J.

Kidney Int. 2018 Jun;93(6):1442-1451. doi: 10.1016/j.kint.2018.01.009. Epub 2018 Mar 29. Erratum in: Kidney Int. 2018 Nov;94(5):1025-1026.

14.

High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Matsushita K, Kwak L, Yang C, Pang Y, Ballew SH, Sang Y, Hoogeveen RC, Jaar BG, Selvin E, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Coresh J, Hirsch AT.

Eur Heart J. 2018 Jul 1;39(25):2412-2419. doi: 10.1093/eurheartj/ehy106.

15.

American Heart Association's Life's Simple 7 at Middle Age and Prognosis After Myocardial Infarction in Later Life.

Mok Y, Sang Y, Ballew SH, Rebholz CM, Rosamond WD, Heiss G, Folsom AR, Coresh J, Matsushita K.

J Am Heart Assoc. 2018 Feb 17;7(4). pii: e007658. doi: 10.1161/JAHA.117.007658.

16.

Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease.

Yang C, Kwak L, Ballew SH, Garimella PS, Jaar BG, Folsom AR, Heiss G, Selvin E, Lutsey PL, Coresh J, Matsushita K.

Atherosclerosis. 2017 Dec;267:167-174. doi: 10.1016/j.atherosclerosis.2017.09.020. Epub 2017 Sep 22.

17.

Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study.

Matsushita K, Kwak L, Sang Y, Ballew SH, Skali H, Shah AM, Coresh J, Solomon S.

J Am Heart Assoc. 2017 Sep 22;6(9). pii: e006259. doi: 10.1161/JAHA.117.006259.

18.

Socioeconomic Status and Incidence of Hospitalization With Lower-Extremity Peripheral Artery Disease: Atherosclerosis Risk in Communities Study.

Vart P, Coresh J, Kwak L, Ballew SH, Heiss G, Matsushita K.

J Am Heart Assoc. 2017 Aug 10;6(8). pii: e004995. doi: 10.1161/JAHA.116.004995.

19.

Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.

Bandak G, Sang Y, Gasparini A, Chang AR, Ballew SH, Evans M, Arnlov J, Lund LH, Inker LA, Coresh J, Carrero JJ, Grams ME.

J Am Heart Assoc. 2017 Jul 19;6(7). pii: e005428. doi: 10.1161/JAHA.116.005428.

20.

Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data.

Matsushita K, Ballew SH, Coresh J, Arima H, Ärnlöv J, Cirillo M, Ebert N, Hiramoto JS, Kimm H, Shlipak MG, Visseren FLJ, Gansevoort RT, Kovesdy CP, Shalev V, Woodward M, Kronenberg F; Chronic Kidney Disease Prognosis Consortium.

Lancet Diabetes Endocrinol. 2017 Sep;5(9):718-728. doi: 10.1016/S2213-8587(17)30183-3. Epub 2017 Jul 14.

21.

Prognostic Value of Chronic Kidney Disease Measures in Patients With Cardiac Disease.

Mok Y, Ballew SH, Matsushita K.

Circ J. 2017 Jul 25;81(8):1075-1084. doi: 10.1253/circj.CJ-17-0550. Epub 2017 Jul 6. Review.

22.

Kidney Function, Proteinuria, and Cancer Incidence: The Korean Heart Study.

Mok Y, Matsushita K, Ballew SH, Sang Y, Jung KJ, Lee S, Jee SH, Coresh J.

Am J Kidney Dis. 2017 Oct;70(4):512-521. doi: 10.1053/j.ajkd.2017.03.018.

PMID:
28601406
23.

Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline.

Rawlings AM, Sharrett AR, Mosley TH, Ballew SH, Deal JA, Selvin E.

Diabetes Care. 2017 Jul;40(7):879-886. doi: 10.2337/dc16-2203. Epub 2017 May 12.

24.

Global Cardiovascular and Renal Outcomes of Reduced GFR.

Thomas B, Matsushita K, Abate KH, Al-Aly Z, Ärnlöv J, Asayama K, Atkins R, Badawi A, Ballew SH, Banerjee A, Barregård L, Barrett-Connor E, Basu S, Bello AK, Bensenor I, Bergstrom J, Bikbov B, Blosser C, Brenner H, Carrero JJ, Chadban S, Cirillo M, Cortinovis M, Courville K, Dandona L, Dandona R, Estep K, Fernandes J, Fischer F, Fox C, Gansevoort RT, Gona PN, Gutierrez OM, Hamidi S, Hanson SW, Himmelfarb J, Jassal SK, Jee SH, Jha V, Jimenez-Corona A, Jonas JB, Kengne AP, Khader Y, Khang YH, Kim YJ, Klein B, Klein R, Kokubo Y, Kolte D, Lee K, Levey AS, Li Y, Lotufo P, El Razek HMA, Mendoza W, Metoki H, Mok Y, Muraki I, Muntner PM, Noda H, Ohkubo T, Ortiz A, Perico N, Polkinghorne K, Al-Radaddi R, Remuzzi G, Roth G, Rothenbacher D, Satoh M, Saum KU, Sawhney M, Schöttker B, Shankar A, Shlipak M, Silva DAS, Toyoshima H, Ukwaja K, Umesawa M, Vollset SE, Warnock DG, Werdecker A, Yamagishi K, Yano Y, Yonemoto N, Zaki MES, Naghavi M, Forouzanfar MH, Murray CJL, Coresh J, Vos T; Global Burden of Disease 2013 GFR Collaborators; CKD Prognosis Consortium; Global Burden of Disease Genitourinary Expert Group.

J Am Soc Nephrol. 2017 Jul;28(7):2167-2179. doi: 10.1681/ASN.2016050562. Epub 2017 Apr 13.

25.

Race, Serum Potassium, and Associations With ESRD and Mortality.

Chen Y, Sang Y, Ballew SH, Tin A, Chang AR, Matsushita K, Coresh J, Kalantar-Zadeh K, Molnar MZ, Grams ME.

Am J Kidney Dis. 2017 Aug;70(2):244-251. doi: 10.1053/j.ajkd.2017.01.044. Epub 2017 Mar 28.

26.

Ankle-brachial index and physical function in older individuals: The Atherosclerosis Risk in Communities (ARIC) study.

Matsushita K, Ballew SH, Sang Y, Kalbaugh C, Loehr LR, Hirsch AT, Tanaka H, Heiss G, Windham BG, Selvin E, Coresh J.

Atherosclerosis. 2017 Feb;257:208-215. doi: 10.1016/j.atherosclerosis.2016.11.023. Epub 2016 Nov 23.

27.

Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.

Carrero JJ, Grams ME, Sang Y, Ärnlöv J, Gasparini A, Matsushita K, Qureshi AR, Evans M, Barany P, Lindholm B, Ballew SH, Levey AS, Gansevoort RT, Elinder CG, Coresh J.

Kidney Int. 2017 Jan;91(1):244-251. doi: 10.1016/j.kint.2016.09.037. Epub 2016 Dec 4.

28.

Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study.

Ballew SH, Chen Y, Daya NR, Godino JG, Windham BG, McAdams-DeMarco M, Coresh J, Selvin E, Grams ME.

Am J Kidney Dis. 2017 Feb;69(2):228-236. doi: 10.1053/j.ajkd.2016.08.034. Epub 2016 Nov 22.

29.

Cardiovascular risk prediction in people with chronic kidney disease.

Matsushita K, Ballew SH, Coresh J.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):518-523. Review.

30.

Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate.

Matsushita K, Chen J, Sang Y, Ballew SH, Shimazaki R, Fukagawa M, Imai E, Coresh J, Hishida A.

Kidney Int. 2016 Nov;90(5):1109-1114. doi: 10.1016/j.kint.2016.08.003. Epub 2016 Sep 22.

PMID:
27666758
31.

Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.

Chen Y, Chang AR, McAdams DeMarco MA, Inker LA, Matsushita K, Ballew SH, Coresh J, Grams ME.

Mayo Clin Proc. 2016 Oct;91(10):1403-1412. doi: 10.1016/j.mayocp.2016.05.018. Epub 2016 Aug 4.

32.

Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study.

Mok Y, Matsushita K, Sang Y, Ballew SH, Grams M, Shin SY, Jee SH, Coresh J.

PLoS One. 2016 Apr 19;11(4):e0153429. doi: 10.1371/journal.pone.0153429. eCollection 2016.

33.

Carotid Intima-Media Thickness and Incident ESRD: The Atherosclerosis Risk in Communities (ARIC) Study.

Pang Y, Sang Y, Ballew SH, Grams ME, Heiss G, Coresh J, Matsushita K.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1197-205. doi: 10.2215/CJN.11951115. Epub 2016 Apr 12.

34.

Antihypertensive Medications and the Prevalence of Hyperkalemia in a Large Health System.

Chang AR, Sang Y, Leddy J, Yahya T, Kirchner HL, Inker LA, Matsushita K, Ballew SH, Coresh J, Grams ME.

Hypertension. 2016 Jun;67(6):1181-8. doi: 10.1161/HYPERTENSIONAHA.116.07363. Epub 2016 Apr 11.

35.

Candidate Surrogate End Points for ESRD after AKI.

Grams ME, Sang Y, Coresh J, Ballew SH, Matsushita K, Levey AS, Greene TH, Molnar MZ, Szabo Z, Kalantar-Zadeh K, Kovesdy CP.

J Am Soc Nephrol. 2016 Sep;27(9):2851-9. doi: 10.1681/ASN.2015070829. Epub 2016 Feb 8.

36.

Past Decline Versus Current eGFR and Subsequent ESRD Risk.

Kovesdy CP, Coresh J, Ballew SH, Woodward M, Levin A, Naimark DM, Nally J, Rothenbacher D, Stengel B, Iseki K, Matsushita K, Levey AS; CKD Prognosis Consortium.

J Am Soc Nephrol. 2016 Aug;27(8):2447-55. doi: 10.1681/ASN.2015060687. Epub 2015 Dec 11.

37.

Influence of chronic kidney disease on cardiac structure and function.

Matsushita K, Ballew SH, Coresh J.

Curr Hypertens Rep. 2015 Sep;17(9):581. doi: 10.1007/s11906-015-0581-x. Review.

PMID:
26194332
38.

A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury.

Grams ME, Sang Y, Ballew SH, Gansevoort RT, Kimm H, Kovesdy CP, Naimark D, Oien C, Smith DH, Coresh J, Sarnak MJ, Stengel B, Tonelli M; CKD Prognosis Consortium.

Am J Kidney Dis. 2015 Oct;66(4):591-601. doi: 10.1053/j.ajkd.2015.02.337. Epub 2015 May 2. Review.

39.

Kidney Failure and ESRD in the Atherosclerosis Risk in Communities (ARIC) Study: Comparing Ascertainment of Treated and Untreated Kidney Failure in a Cohort Study.

Rebholz CM, Coresh J, Ballew SH, McMahon B, Whelton SP, Selvin E, Grams ME.

Am J Kidney Dis. 2015 Aug;66(2):231-9. doi: 10.1053/j.ajkd.2015.01.016. Epub 2015 Mar 12.

40.

Association of kidney function and albuminuria with prevalent and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) study.

Huang M, Matsushita K, Sang Y, Ballew SH, Astor BC, Coresh J.

Am J Kidney Dis. 2015 Jan;65(1):58-66. doi: 10.1053/j.ajkd.2014.06.025. Epub 2014 Aug 21.

41.

Subclinical atherosclerosis measures for cardiovascular prediction in CKD.

Matsushita K, Sang Y, Ballew SH, Shlipak M, Katz R, Rosas SE, Peralta CA, Woodward M, Kramer HJ, Jacobs DR, Sarnak MJ, Coresh J.

J Am Soc Nephrol. 2015 Feb;26(2):439-47. doi: 10.1681/ASN.2014020173. Epub 2014 Aug 21.

42.

Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.

Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS.

JAMA. 2014 Jun 25;311(24):2518-2531. doi: 10.1001/jama.2014.6634.

43.

Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.

Matsushita K, Sang Y, Ballew SH, Astor BC, Hoogeveen RC, Solomon SD, Ballantyne CM, Woodward M, Coresh J.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1770-7. doi: 10.1161/ATVBAHA.114.303465. Epub 2014 May 29.

44.

Identification of incident CKD stage 3 in research studies.

Grams ME, Rebholz CM, McMahon B, Whelton S, Ballew SH, Selvin E, Wruck L, Coresh J.

Am J Kidney Dis. 2014 Aug;64(2):214-21. doi: 10.1053/j.ajkd.2014.02.021. Epub 2014 Apr 13.

45.

Performance and limitations of administrative data in the identification of AKI.

Grams ME, Waikar SS, MacMahon B, Whelton S, Ballew SH, Coresh J.

Clin J Am Soc Nephrol. 2014 Apr;9(4):682-9. doi: 10.2215/CJN.07650713. Epub 2014 Jan 23.

46.

CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race.

Hui X, Matsushita K, Sang Y, Ballew SH, Fülöp T, Coresh J.

Am J Kidney Dis. 2013 Oct;62(4):691-702. doi: 10.1053/j.ajkd.2013.04.010. Epub 2013 Jun 13.

47.

Cohort profile: the chronic kidney disease prognosis consortium.

Matsushita K, Ballew SH, Astor BC, Jong PE, Gansevoort RT, Hemmelgarn BR, Levey AS, Levin A, Wen CP, Woodward M, Coresh J; Chronic Kidney Disease Prognosis Consortium.

Int J Epidemiol. 2013 Dec;42(6):1660-8. doi: 10.1093/ije/dys173. Epub 2012 Dec 12.

PMID:
23243116
48.

Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control.

Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL.

Diabetes Care. 2011 Sep;34(9):1934-42. doi: 10.2337/dc11-0366. Epub 2011 Jul 25. Erratum in: Diabetes Care. 2013 Nov;36(11):3850.

49.

The role of spiritual experiences and activities in the relationship between chronic illness and psychological well-being.

Ballew SH, Hannum SM, Gaines JM, Marx KA, Parrish JM.

J Relig Health. 2012 Dec;51(4):1386-96. doi: 10.1007/s10943-011-9498-0.

PMID:
21604081
50.

Repeat falls and the recovery of social participation in the year post-hip fracture.

Miller RR, Ballew SH, Shardell MD, Hicks GE, Hawkes WG, Resnick B, Magaziner J.

Age Ageing. 2009 Sep;38(5):570-5. doi: 10.1093/ageing/afp107. Epub 2009 Jul 8.

Supplemental Content

Loading ...
Support Center